Total Payments
$333.48
2024 Payments
$87.39
Companies
13
Transactions
17
Medicare Patients
704
Medicare Billing
$106,525
Payment Breakdown by Category
Food & Beverage$333.48 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $333.48 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $47.28 | 3 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $36.93 | 2 | $0 (2024) |
| Lilly USA, LLC | $34.84 | 2 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $31.25 | 1 | $0 (2022) |
| Eisai Inc. | $27.21 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $24.54 | 1 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $23.03 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.06 | 1 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $18.80 | 1 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $18.70 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $87.39 | 4 | Eisai Inc. ($27.21) |
| 2023 | $85.98 | 5 | Lilly USA, LLC ($34.84) |
| 2022 | $124.73 | 6 | Novo Nordisk Inc ($33.42) |
| 2021 | $16.84 | 1 | Avanir Pharmaceuticals, Inc. ($16.84) |
| 2018 | $18.54 | 1 | AstraZeneca Pharmaceuticals LP ($18.54) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: PSYCHIATRY | ||||||
| 04/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: UROLOGY | ||||||
| 03/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Neuropsychiatry | ||||||
| 03/13/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: Neurology | ||||||
| 10/10/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: UROLOGY | ||||||
| 09/12/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/26/2023 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 11/22/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Central Nervous System | ||||||
| 10/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 09/13/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Cardio-renal | ||||||
| 08/03/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Diabetes | ||||||
| 04/05/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/11/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/29/2021 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/19/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 353 | 627 | $120,788 | $55,248 |
| 2022 | 5 | 351 | 639 | $124,053 | $51,277 |
Total Patients
704
Total Services
1,266
Medicare Billing
$106,525
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 114 | 255 | $45,900 | $18,895 | 41.2% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 72 | 162 | $29,160 | $13,820 | 47.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 52 | 53 | $19,080 | $7,812 | 40.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 32 | 46 | $9,154 | $5,578 | 60.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 24 | 31 | $6,169 | $3,648 | 59.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 33 | 53 | $7,950 | $2,937 | 36.9% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 26 | 27 | $3,375 | $2,556 | 75.7% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 118 | 278 | $50,040 | $20,026 | 40.0% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 66 | 142 | $25,560 | $10,645 | 41.6% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 45 | 46 | $16,560 | $6,136 | 37.1% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 32 | 54 | $10,746 | $5,930 | 55.2% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 16 | 23 | $4,577 | $2,540 | 55.5% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 37 | 52 | $7,800 | $2,302 | 29.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 12 | 12 | $4,320 | $1,631 | 37.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 14 | 14 | $1,750 | $1,198 | 68.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 11 | 18 | $2,700 | $871.05 | 32.3% |
About Dr. Stephen Lazar, DO
Dr. Stephen Lazar, DO is a Internal Medicine healthcare provider based in Stratford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2014. The National Provider Identifier (NPI) number assigned to this provider is 1134549330.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Lazar, DO has received a total of $333.48 in payments from pharmaceutical and medical device companies, with $87.39 received in 2024. These payments were reported across 17 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($333.48).
As a Medicare-enrolled provider, Lazar has provided services to 704 Medicare beneficiaries, totaling 1,266 services with total Medicare billing of $106,525. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Geriatric Medicine
- Location Stratford, NJ
- Active Since 04/26/2014
- Last Updated 09/24/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134549330
Products in Payments
- GEMTESA (Drug) $36.93
- Rybelsus (Drug) $32.53
- Kerendia (Drug) $31.25
- Leqembi (Drug) $27.21
- ENTRESTO (Drug) $24.54
- INGREZZA (Drug) $23.03
- MOUNJARO (Drug) $21.68
- GATTEX (Drug) $21.06
- REXULTI (Drug) $18.80
- NUPLAZID (Drug) $18.70
- FARXIGA (Drug) $18.54
- Nuedexta (Drug) $16.84
- Ozempic (Drug) $14.75
- AUSTEDO (Drug) $14.46
- TRULICITY (Drug) $13.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Stratford
Dr. Edward Carreras, M.d, M.D
Internal Medicine — Payments: $27,269
Internal Medicine $27,269
Dr. Lucia Chou, M.d, M.D
Internal Medicine — Payments: $21,643
Internal Medicine $21,643
Panayotes Yannopoulos, Md, MD
Internal Medicine — Payments: $17,274
Internal Medicine $17,274
Dr. Bobby Malik, Md, MD
Internal Medicine — Payments: $11,929
Internal Medicine $11,929
Leonid Karkanitsa, Md, MD
Internal Medicine — Payments: $8,720
Internal Medicine $8,720
Dr. Magdala Chery, D.o, D.O
Internal Medicine — Payments: $6,644
Internal Medicine $6,644